The CRISPR–Cas system in clinical strains of Acinetobacter baumannii : an in-silico analysis
Letters in Applied Microbiology · 2024
DOI: 10.1093/lambio/ovae003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Applied Microbiology, 2024. Verfasst von Arturo Martínez-Trejo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Investigación Clínica y Ambiental, Departamento de Microbiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacio…. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Bacteriophages. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Consejo Nacional de Humanidades, Ciencias y Tecnologías, Sistema Nacional de Investigadores.
Abstract (Originalsprache)
Acinetobacter baumannii is a relevant bacterium due to its high-resistance profile. It is well known that antimicrobial resistance is primarily linked to mutations and the acquisition of external genomic material, such as plasmids or phages, to which the Clustered Regularly Interspaced Short Palindromic Repeats associated with Cas proteins, or CRISPR–Cas, system is related. It is known that the system can influence the acquisition of foreign genetic material and play a role in various physiological pathways. In this study, we conducted an in-silico analysis using 91 fully assembled genomes of clinical strains obtained from the NCBI database. Among the analyzed genomes, the I-F1 subtype of the CRISPR–Cas system was detected showcasing variations in architecture and phylogeny. Using bioinformatic tools, we determined the presence, distribution, and specific characteristics of the CRISPR–Cas system. We found a possible association of the system with resistance genes but not with virulence determinants. Analysis of the system’s components, including spacer sequences, suggests its potential role in protecting against phage infections, highlighting its protective function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratorio de Investigación Clínica y Ambiental, Departamento de Microbiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City 11340, Mexico.
- Laboratorio Clínico, Unidad Médica de Alta Especialidad, Hospital de Pediatría Dr. Silvestre Frenk Freud, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.
- Laboratorio de Bioquímica Microbiana, Departamento de Microbiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City 11340, Mexico.
- División de Investigación, Hospital Juárez de México, Mexico City 07760,Mexico.
ORCID-Profile: Arturo Martínez-Trejo, Andres Saldaña-Padilla, Graciela Castro-Escarpulli
Förderung
- Consejo Nacional de Humanidades, Ciencias y Tecnologías
- Sistema Nacional de Investigadores
Zitieren
APA
Martínez-Trejo, A., Ruiz-Ruiz, J. M., Gonzalez-Avila, L. U., Saldaña-Padilla, A., Hernández-Cortez, C., de Jesús Colmenero-Solís, R., Bello-López, J. M., & Castro-Escarpulli, G. (2024). The CRISPR–Cas system in clinical strains of Acinetobacter baumannii : an in-silico analysis. Letters in Applied Microbiology. https://doi.org/10.1093/lambio/ovae003
Vancouver
Martínez-Trejo A, Ruiz-Ruiz JM, Gonzalez-Avila LU, Saldaña-Padilla A, Hernández-Cortez C, de Jesús Colmenero-Solís R, et al. The CRISPR–Cas system in clinical strains of Acinetobacter baumannii : an in-silico analysis. Letters in Applied Microbiology. 2024. doi:10.1093/lambio/ovae003
BibTeX
@article{MartnezTrejo2024,
author = {Martínez-Trejo, Arturo and Ruiz-Ruiz, Juan Manuel and Gonzalez-Avila, Luis Uriel and Saldaña-Padilla, Andres and Hernández-Cortez, Cecilia and de Jesús Colmenero-Solís, Raúl and Bello-López, Juan Manuel and Castro-Escarpulli, Graciela},
title = {The CRISPR–Cas system in clinical strains of Acinetobacter baumannii : an in-silico analysis},
journal = {Letters in Applied Microbiology},
year = {2024},
doi = {10.1093/lambio/ovae003}
}
EUVIMED